Moira A Rynn

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy
    Moira Rynn
    Mood and Anxiety Disorders Section, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104 3309, USA
    J Clin Psychopharmacol 23:505-8. 2003
  2. ncbi request reprint Early response and 8-week treatment outcome in GAD
    Moira Rynn
    Mood and Anxiety Disorders Section, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
    Depress Anxiety 23:461-5. 2006
  3. ncbi request reprint Long-term sertraline treatment of children and adolescents with major depressive disorder
    Moira Rynn
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Child Adolesc Psychopharmacol 16:103-16. 2006
  4. ncbi request reprint The psychometric properties of the MASC in a pediatric psychiatric sample
    Moira A Rynn
    Department of Psychiatry, Mood and Anxiety Disorders Program, Center for Psychotherapy Research, Suite 670, University of Pennsylvania School of Medicine, 3535 Market Street, Philadelphia, PA 19104 3309, USA
    J Anxiety Disord 20:139-57. 2006
  5. ncbi request reprint Generalized anxiety disorder: acute and chronic treatment
    Moira A Rynn
    Mood and Anxiety Disorders Section, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, USA
    CNS Spectr 9:716-23. 2004
  6. doi request reprint Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial
    Jacques P Barber
    Center for Psychotherapy Research, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, USA
    J Clin Psychiatry 73:66-73. 2012
  7. doi request reprint Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release
    Karl Rickels
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    Arch Gen Psychiatry 67:1274-81. 2010
  8. ncbi request reprint Paroxetine in the treatment of generalised anxiety disorder
    Steven H Snyderman
    Mood and Anxiety Disorders Section, Department of Psychiatry, University of Pennsylvania School of Medicine, 3535 Market Street, Suite 670, Philadelphia, PA 19104, USA
    Expert Opin Pharmacother 5:1799-806. 2004
  9. ncbi request reprint Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial
    Alan D Feiger
    Department of Psychiatry, University of Colorado School of Medicine, Denver, CO, USA
    J Clin Psychiatry 67:1354-61. 2006
  10. ncbi request reprint Social anxiety disorder in children and adolescents: epidemiology, diagnosis, and treatment
    Sarosh Khalid-Khan
    Department of Psychiatry, Mood and Anxiety Disorders Clinic, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Paediatr Drugs 9:227-37. 2007

Research Grants

Detail Information

Publications12

  1. ncbi request reprint Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy
    Moira Rynn
    Mood and Anxiety Disorders Section, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104 3309, USA
    J Clin Psychopharmacol 23:505-8. 2003
    ..Neither discontinuation severity nor taper-free status 12 weeks posttaper differed between the 3 treatment groups...
  2. ncbi request reprint Early response and 8-week treatment outcome in GAD
    Moira Rynn
    Mood and Anxiety Disorders Section, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
    Depress Anxiety 23:461-5. 2006
    ..001). Early improvement was a strong predictor for treatment outcome irrespective of whether active medication or placebo was the treatment agent...
  3. ncbi request reprint Long-term sertraline treatment of children and adolescents with major depressive disorder
    Moira Rynn
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Child Adolesc Psychopharmacol 16:103-16. 2006
    ....
  4. ncbi request reprint The psychometric properties of the MASC in a pediatric psychiatric sample
    Moira A Rynn
    Department of Psychiatry, Mood and Anxiety Disorders Program, Center for Psychotherapy Research, Suite 670, University of Pennsylvania School of Medicine, 3535 Market Street, Philadelphia, PA 19104 3309, USA
    J Anxiety Disord 20:139-57. 2006
    ..The MASC is a clinically useful measure to discriminate between anxious and depressed pediatric patients. Limitations due to the highly selective sample are noted...
  5. ncbi request reprint Generalized anxiety disorder: acute and chronic treatment
    Moira A Rynn
    Mood and Anxiety Disorders Section, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, USA
    CNS Spectr 9:716-23. 2004
    ..There is still an urgent need to explore treatment combinations and duration strategies in the management of patients suffering with GAD...
  6. doi request reprint Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial
    Jacques P Barber
    Center for Psychotherapy Research, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, USA
    J Clin Psychiatry 73:66-73. 2012
    ....
  7. doi request reprint Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release
    Karl Rickels
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    Arch Gen Psychiatry 67:1274-81. 2010
    ..Generalized anxiety disorder (GAD) is a chronic disorder in need of reliable data to guide long-term treatment...
  8. ncbi request reprint Paroxetine in the treatment of generalised anxiety disorder
    Steven H Snyderman
    Mood and Anxiety Disorders Section, Department of Psychiatry, University of Pennsylvania School of Medicine, 3535 Market Street, Suite 670, Philadelphia, PA 19104, USA
    Expert Opin Pharmacother 5:1799-806. 2004
    ....
  9. ncbi request reprint Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial
    Alan D Feiger
    Department of Psychiatry, University of Colorado School of Medicine, Denver, CO, USA
    J Clin Psychiatry 67:1354-61. 2006
    ..This study investigated the efficacy, safety, and tolerability of the selegiline transdermal system (STS) administered in a dose range of 6 mg/24 hours to 12 mg/24 hours for treating major depressive disorder (MDD)...
  10. ncbi request reprint Social anxiety disorder in children and adolescents: epidemiology, diagnosis, and treatment
    Sarosh Khalid-Khan
    Department of Psychiatry, Mood and Anxiety Disorders Clinic, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Paediatr Drugs 9:227-37. 2007
    ..There is some evidence that the use of combination therapy, both pharmacology and psychosocial treatment, is beneficial in the management of pediatric SOC...
  11. ncbi request reprint Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials
    Moira A Rynn
    New York State Psychiatric Institute, 1051 Riverside Drive, Unit 74, New York, NY 10032, USA
    Am J Psychiatry 164:290-300. 2007
    ..The authors evaluated the efficacy, safety, and tolerability of extended-release venlafaxine in the treatment of pediatric generalized anxiety disorder...
  12. ncbi request reprint Open-label pilot study of ziprasidone for refractory generalized anxiety disorder
    Steven H Snyderman
    J Clin Psychopharmacol 25:497-9. 2005

Research Grants1

  1. TREATMENT OUTCOMES FOR CHILDREN WITH ANXIETY DISORDERS
    Moira Rynn; Fiscal Year: 2004
    ..Families will be followed for one year to collect for further research. ..